Similar articles

• Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.

  Walters JR, Roth RH. Walters JR, et al. Naunyn Schmiedebergs Arch Pharmacol. 1976 Dec;296(1):5-14. doi: 10.1007/BF00498834. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 13315
• A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.

  Hartley EJ, Spuhler K, Prasad KN, Seeman P. Hartley EJ, et al. Brain Res. 1980 May 26;190(2):574-7. doi: 10.1016/0006-8993(80)90302-9. Brain Res. 1980. PMID: 6154511 No abstract available.
• Dopamine receptors in the brain.

  Iversen LL. Iversen LL. Science. 1975 Jun 13;188(4193):1084-9. doi: 10.1126/science.2976. Science. 1975. PMID: 2976 Review. No abstract available.
• Anti-schizophrenic drugs--membrane receptor sites of action.

  Seeman P. Seeman P. Biochem Pharmacol. 1977 Oct 1;26(19):1741-8. doi: 10.1016/0006-2952(77)90340-9. Biochem Pharmacol. 1977. PMID: 20896 Review. No abstract available.
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  Creese I, Burt DR, Snyder SH. Creese I, et al. Science. 1976 Apr 30;192(4238):481-3. doi: 10.1126/science.3854. Science. 1976. PMID: 3854